本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

16.38
+0.22501.39%
成交量:40.34萬
成交額:660.37萬
市值:19.07億
市盈率:-12.52
高:16.55
開:16.18
低:16.01
收:16.15
52周最高:21.45
52周最低:9.82
股本:1.16億
流通股本:9,642.36萬
量比:0.53
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
淨資產收益率:-43.22%
總資產收益率:-9.26%
市淨率:5.64
市盈率(LYR):-13.40

資料載入中...

2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/22

重要事件披露

Form 8-K - Current report
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities